Flagship Harbor Advisors, LLC Akebia Therapeutics, Inc. Transaction History

Flagship Harbor Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$2.22 - $3.78 $206 - $351	-93 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$2.39 - $13.08 $1,902 - $10,411	-796 Reduced 89.54%	93 $0
Q2 2020 Jul 31, 2020	BUY	$6.67 - $13.58 $2,814 - $5,730	422 Added 90.36%	889 $12,000
Q4 2018 Jan 28, 2019	BUY	$5.39 - $9.15 $242 - $411	45 Added 10.66%	467 $2,000
Q3 2018 Nov 05, 2018	BUY	$7.44 - $10.65 $2,418 - $3,461	325 Added 335.05%	422 $4,000
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $887 - $1,099	97 New	97 $0

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.